Raymond James Financial’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72.4K Sell
1,357
-35,161
-96% -$1.88M ﹤0.01% 4968
2025
Q1
$1.48M Buy
+36,518
New +$1.48M ﹤0.01% 3193